Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
Powis J, Peltekian KM, Lee SS, Sherman M, Bain VG, Cooper C, Krajden M, Deschenes M, Balshaw RF, Heathcote EJ, Yoshida EM; Canadian Pegasys Study Group. Powis J, et al. Among authors: heathcote ej. J Viral Hepat. 2008 Jan;15(1):52-7. doi: 10.1111/j.1365-2893.2007.00889.x. J Viral Hepat. 2008. PMID: 18088245 Free PMC article. Clinical Trial.
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, Heathcote EJ, Brown NA, Atkins M, Woessner M, Gardner SD. Perrillo RP, et al. Among authors: heathcote ej. Hepatology. 2002 Jul;36(1):186-94. doi: 10.1053/jhep.2002.34294. Hepatology. 2002. PMID: 12085364 Clinical Trial.
Endpoints of therapy in chronic hepatitis B.
Feld JJ, Wong DK, Heathcote EJ. Feld JJ, et al. Among authors: heathcote ej. Hepatology. 2009 May;49(5 Suppl):S96-S102. doi: 10.1002/hep.22977. Hepatology. 2009. PMID: 19399800
Re-treatment of chronic hepatitis C with consensus interferon.
Heathcote EJ, Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, Albert DG Jr, Witt K, Blatt LM. Heathcote EJ, et al. Hepatology. 1998 Apr;27(4):1136-43. doi: 10.1002/hep.510270431. Hepatology. 1998. PMID: 9537455 Clinical Trial.
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ. Kilmurry MR, et al. Among authors: heathcote ej. Hepatology. 1996 May;23(5):1148-53. doi: 10.1002/hep.510230532. Hepatology. 1996. PMID: 8621147 Clinical Trial.
180 results